Phosphorothioate backbone modification enhances aptamer-drug conjugate for pancreatic cancer therapy

FHS
July 10, 2023
6:59 pm

Pancreatic cancer is a complex and deadly solid tumor that poses significant challenges for both diagnosis and treatment.

Study uncovers genetic clues to the cause of restless leg syndrome

Scientists have discovered genetic clues to the cause of restless leg syndrome, a condition common among older adults.

June 5, 2024

Hemoglobin Targets a Good Idea for Massively Transfused Patients

SAN FRANCISCO — Critically ill patients receiving blood transfusions of 10 or more units had substantially better survival when it brought hemoglobin levels close to

October 17, 2023

Almirall’s Ebglyss recommended by NICE for NHS atopic dermatitis patients

Almirall S.A., a global biopharmaceutical company dedicated to medical dermatology, announced today that the National Institute for Health and Care Excellence (NICE) has recommended Ebglyss

July 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.